Capewell S, Morrison C E, McMurray J J
University of Glasgow, Department of Public Health, 2 Lilybank Gardens, Glasgow G12 8RZ, UK.
Heart. 1999 Apr;81(4):380-6. doi: 10.1136/hrt.81.4.380.
To estimate the fall in coronary heart disease (CHD) mortality in Scotland attributable to medical and surgical treatments, and risk factor changes, between 1975 and 1994.
A cohort model combining effectiveness data from meta-analyses with information on treatment uptake in all patient categories in Scotland.
The whole Scottish population of 5.1 million, including all patients with recognised CHD.
All cardiological, medical, and surgical treatments, and all risk factor changes between 1975 and 1994. Data were obtained from epidemiological surveys, routine National Health Service sources, and local audits.
Deaths from CHD in 1975 and 1994.
There were 15 234 deaths from CHD in 1994, 6205 fewer deaths than expected if there had been no decline from 1975 mortality rates. In 1994, the total number of deaths prevented or postponed by all treatments and risk factor reductions was estimated at 6747 (minimum 4790, maximum 10 695). Forty per cent of this benefit was attributed to treatments (initial treatments for acute myocardial infarction 10%, treatments for hypertension 9%, for secondary prevention 8%, for heart failure 8%, aspirin for angina 2%, coronary artery bypass grafting surgery 2%, and angioplasty 0.1%). Fifty one per cent of the reduction in deaths was attributed to measurable risk factor reductions (smoking 36%, cholesterol 6%, secular fall in blood pressure 6%, and changes in deprivation 3%). Other, unquantified factors apparently accounted for the remaining 9%. These proportions remained relatively consistent across a wide range of assumptions and estimates in a sensitivity analysis.
Medical treatments and risk factor changes apparently prevented or postponed about 6750 coronary deaths in Scotland in 1994. Modest gains from individual treatments produced a large cumulative survival benefit. Reductions in major risk factors explained about half the fall in coronary mortality, emphasising the importance and future potential of prevention strategies.
评估1975年至1994年间,苏格兰因医学和外科治疗以及危险因素变化导致的冠心病(CHD)死亡率下降情况。
一种队列模型,将荟萃分析的有效性数据与苏格兰所有患者类别中治疗采用情况的信息相结合。
苏格兰全体人口510万,包括所有确诊的冠心病患者。
1975年至1994年间的所有心脏病学、医学和外科治疗以及所有危险因素变化。数据来自流行病学调查、国家卫生服务常规来源和地方审计。
1975年和1994年的冠心病死亡人数。
1994年有15234例冠心病死亡病例,若自1975年以来死亡率未下降,死亡人数将比预期多6205例。1994年,所有治疗和危险因素降低预防或推迟的死亡总数估计为6747例(最小值4790例,最大值10695例)。这一益处的40%归因于治疗(急性心肌梗死初始治疗10%,高血压治疗9%,二级预防8%,心力衰竭治疗8%,心绞痛用阿司匹林2%,冠状动脉搭桥手术2%,血管成形术0.1%)。死亡人数减少的51%归因于可测量的危险因素降低(吸烟36%,胆固醇6%,血压长期下降6%,贫困状况变化3%)。其他未量化因素显然占其余的9%。在敏感性分析中,这些比例在广泛的假设和估计范围内保持相对一致。
1994年,医学治疗和危险因素变化显然在苏格兰预防或推迟了约6750例冠心病死亡。个体治疗的适度获益产生了巨大的累积生存益处。主要危险因素的降低解释了约一半的冠心病死亡率下降,强调了预防策略的重要性和未来潜力。